Respiratory Immunology 5: Vaccination Flashcards

1
Q

What is vaccination, why is it done and how is the effect achieved?

A

Deliberate exposure to an antigen in order to induce immunologically mediated resistance to disease, through induction of memory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Generation of immunological memory?

A

Stimulation and maturation of the immune response after exposure to an antigen, such that is able to respond immediately and robustly upon re-exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Generation of memory B cells?

A

Long-lived MEMORY B CELLS are generated during primary humoral immune responses

Memory B cells can survive in a dormant state for many years after antigen has been eliminated

Memory B cells rapidly re-activate in response to a second encounter with that specific antigen - clonal expansion, differentiation into plasma cells, antibody production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Impact of memory on antibody production?

A

Primary infection - during incubation period, IgM antibody being produced and IgG antibody is produced later on, towards the end of clinical disease presentation

Secondary infection - IgG antibody produced immediately due to memory B cells and so clinical features do not present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe secondary antibody response

A

Pre-existing IgG antibody results in ability to clear during incubation periods:

Direct action to neutralise bacteria and bacterial products

Rapid mobilisation of phagocytes and complement

Pre-formed IgA blocks bacterial attachment to mucous membranes`

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clearing of toxin in Diphtheria?

A

Individual may clear toxin through anti-toxin antibodies, but remain a carrier of micro-organism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How is T cell memory generated through vaccination?

A

Vaccination simulates rare naive T cells and induces a strong T cell response in 14-21 days; some become EFFECTOR T cells which:

Mostly die by apoptosis in absence of persisting antigen

Smaller number become MEMORY CELLS and are maintained at low frequency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Memory T cell characteristics?

A

Make a MORE EFFECTIVE IMMUNE RESPONSE:

Primed CD8 T cells can immediately kill without immunological “help”

Primed CD4 T cells can produce cytokines immediately

Have enhanced properties of cell adhesion and chemotaxis - memory cells can access non-lymphoid tissues effectively, where bugs actually are

LONGEVITY - memory T cells can be maintained for a long time without antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How long does memory last?

A

A long time - e.g: re-exposure to measles virus is unnecessary in maintaining memory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Types of vaccination?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Difference between immunisation and vaccination?

A

Immunisation - process through which an individual develops immunity/memory to a disease (inc. both deliberate and natural infection)

Vaccination - deliberate administration of antogenic material to produce immunity to a disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is active immunity?

A

Protection produced by the person’s own immune system; can be stimulated by vaccine/naturally acquired infection and is usually permanent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is passive immunity?

A

Protection transferred from another person or animals but is temporary and wanes with time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe active vaccination

A

Stimulates immune response to antigen through SAME PATHWAYS AS NATURAL INFECTION; thus generates immunity and memory similar to natural infection

MORE SIMILAR A VACCINE IS TO DISEASE-CAUSING FORM OF ORGANISM, BETTER THE IMMUNE RESPONSE TO DISEASE IS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Methods for generating immunological memory?

A

Exposure of an individual to INFECTIOUS ORGANISM ITSELF

Exposure to a SIMILAR PATHODEN that is LESS VIRULENT

Exposure to the INACTIVATED PATHOGEN

Exposure to a LESS VIRULENT VERSION of the SAME PATHOGEN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is variolation?

A

Predecessor of vaccination - exposure to contents of dried smallpox pustules from infected patient, optimally from people with less severe disease 1:100 died

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Principle of exposure to a similar but less virulent pathogen?

A

One disease is being induced to generate cross-reactive immunity against another disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Example of exposure to a similar but less virulent pathogen?

A

Immunisation with cowpox protecting against smallpox as:

Molecular similarities between cowpox and smallpox

Antibodies generated through exposure to cowpox cross-react with smallpox, neutralising the smallpox virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Inactivated vaccines AKA?

A

ATTENUATED or killed (not a good term as some inactivated vaccines are made from components and were not alive before) vaccines

20
Q

Key features of inactivated vaccines?

A

Cannot replicate but generally not as effective as live vaccines

Immune response PRIMARILY ANTIBODY-BASED (not T cells); antibody titre may diminish with time and may require MULTIPLE DOSES to stimulate immune response

21
Q

How to make an inactive vaccine from a live pathogen?

A

Expose pathogen to chemical fixative, e.g: formalin, heat denaturation or irradiation

22
Q

Problems with inactive vaccines?

A

Under-activation - leaves viable pathogens/toxins within organism

Over-activation - loss of tertiary structure and conformational antibody binding sites

23
Q

What is poliomyelitis?

A

Caused by POLIO VIRUS, which is transmitted via oro-faecal route

24
Q

Clinical presentation of poliomyelitis?

A

90-95% of infections are asymptomatic - may still transmit disease

5% have minor flu-like illness

0.5% cases develop muscle weakness and paralysis - may develop post-polio syndrome

25
Q

Describe polio vaccine

A

Sabin Polio vaccine - LIVE ATTENUATED polio virus strains. Unsafe in immunocompromised host

26
Q

Advantages of inactivated vaccines?

A

Can be made quickly, prevent epidemics

May elicit good antibody responses

Easy to store - no refrigeration required USUALLY safe - can be given to immunocompromised individuals

27
Q

Disadvantages of inactivated vaccines?

A

May be difficult to stimulate an immune response to many killed organisms - does not replicate of disseminate and often require ADJUVANTS to improve immunogenicity

Poor at eliciting T cell responses

Memory variable - requires multiple injections, booster immunisation requries

28
Q

What are adjuvants?

A

Mixture of inflammatory substances required to stimulate immune responses (co-administered peptides, proteins or carbohydrates)

Other pathogens - like Bordetella pertussis

29
Q

Why do adjuvants work?

A

Create inflammatory environment:

Bind to macrophages and signal the unequivocal presence of a microbial invader

Activate innate immune system to stimulate development of antibody and T cell responses

30
Q

Problems with adjuvants?

A

Toxic

Alter the immune response - generated to vaccine:protein conjugates rather than vaccine itself CD4+ T cells may recognise the carrier only; thus, infection challenge will not necessarily elicit a secondary response

31
Q

Types of inactivated vaccines?

A

Whole cell vaccines, i.e: whole organism used

Fractional vaccines - only part of the organism used in the vaccine:

Sub-unit vaccines

Pure polysaccharide vaccines

32
Q

Describe the Hep B vaccine

A

First of the anti-cancer vaccines - protects against Hep B associated hepatocellular cancer

33
Q

Describe polysaccharide vaccines

A

Polysaccharide sugars from the outer capsule of some bacteria determines pathogenicity and antigenicity but they are not good at stimulating responses (generates antibody with less functional activity, esp. in immature immune system)

Immunogenicity can be improved by conjugating to an adjuvant (CONJUGATE VACCINES)

34
Q

What are live attenuated vaccines?

A

Less virulent version of the same pathogen Attenuated/weakened form of “wild” virus/bacterium; the immune response is similar to natural infection Organism must replicate to be effective and usually generates immunity with single dose

35
Q

Examples of live attenuated vaccines?

A

Viruses - measles, mumps, rubella, chickenpox Bacterial - BCG

36
Q

Advantages of live attenuated vaccines?

A

Very similar to natural infection, so relevant effector mechanisms elicited (antibody, activated T cells)

Localised, strong response

Memory good so boosting not usually required

37
Q

Disadvantages of live attenuated vaccines?

A

Immune response can be interfered with by circulating antibody

Safety - may require new mutations and revert to virulence, e.g: vaccine-associated poliomyelitis, and MAY CAUSE INFECTION IN IMMUNOCOMPROMISED HOST

Fragile - must be stored and handled carefully, i.e: depends on cold chain

38
Q

Example of naturally acquired passive immunity?

A

Transplacental transfer of antibody

39
Q

Describe transplacental transfer of antibody and in breast milk

A

Maternal antibody is crucial to protection of infant in 1st 6 months of life; there is active transport of maternal IgG in 3rd trimester;

Via breast milk, esp. colostrum, containing IgA (important for colonisation of infant GI tract)

Maternal antibody also important in enabling subsequent memory - exposure to an antigen while under cover of maternal antibody may result in a less severe illness but memory to antigen is generated

40
Q

Examples of therapeutic passive immunisation?

A

Pooled normal human immunoglobulin

Monoclonal antibody against specific pathogen

41
Q

What is pooled immunoglobulin?

A

Transfer of antibody from an unrelated individual:

Pooled normal immunoglobulin from immune humans - used for protection from Hep A

Hyperimmune globulin - administered after specific exposure; immunoglobulin from an individual known to have high antibody levels against a specific pathogen (rabies - post exposure, snake venom anti-toxin)

42
Q

Describe passive immunisation with monoclonal antibodies for Respiratory Syncitial Virus and what the indications are

A

Palivizumab - monoclonal antibody produced against a single determinant of Respiratory Syncitial Virus (RSV)

Indications - prevention of severe LRT infections in high-risk infants (may have severe congenital heart disease; pre-term infants, severe chronic lung disease

43
Q

Organisms difficult to create vaccines against?

A

Chronic or latent infections - immune system does not normally generate a response that clears organisms, e.g: TB, Hep B, HIV, herpes viruses)

Rapidly evolving infections - pathogens highly adept at immune evasion, e.g: HIV, Influenza

44
Q

Cancer preventative vaccines?

A

Hep B HPV

45
Q

Describe addiction vaccines

A

Drugs of abuse are small molecule and readily cross blood-brain barrier

Addiction vaccines aim to reduce drug levels in the brain - stimulate antibody which binds to drug before it enters brain so cannot cross barrier